Clinical Trial Update: Study of Testosterone and rHGH in FSHD [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating testosterone and recombinant human growth hormone in facioscapulohumeral muscular dystrophy has completed; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy

Drugs mentioned

• Recombinant human growth hormone (somatropin)
• TESTOSTERONE (testosterone)

Snippet

Sponsor: University of Rochester | Conditions: Facioscapulohumeral Muscular Dystrophy | Phase 1 | Status: COMPLETED | Results posted: 2023-05-16